Previous research has demonstrated that the CSGALNACT2 expression was positively associated with the level of immune cells (including dendritic cell, neutrophil, macrophage, CD4+T Cell, and CD8+T Cell), and high expression of CSGALNACT2 was significantly associated with shorter overall survival (OS) rate in COAD and READ [23]. Here, CSGALNACT2 is linked to colon adenocarcinoma.